|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Clinical Nutrition and Risk Factor Modification Center (DJAJ, CWCK, AM, DAF, JMWW, RdS, AE, TLP, EV, RGJ, LAL, and WS) and the Department of Medicine, Division of Endocrinology and Metabolism (DJAJ, RGJ, LAL, WS, and PWC), St Michael's Hospital, Toronto; the Departments of Nutritional Sciences (DJAJ, CWCK, AM, DAF, JMWW, RdS, AE, TLP, EV, RGJ, LAL, and WS) and Medicine (DJAJ, RGJ, LAL, PWC, and WS), and the Laboratory of Medicine and Pathobiology, Faculty of Medicine (PWC), University of Toronto; the Unilever Health Institute, Unilever R&D, Vlaardingen, Netherlands (EAT); and the Almond Board of California, Modesto, CA (KGL)
Background: 3-Hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors reduce serum cholesterol and are increasingly advocated in primary prevention to achieve reductions in LDL cholesterol. Newer dietary approaches combining cholesterol-lowering foods may offer another option, but these approaches have not been compared directly with statins in the same persons.
Objective: The objective was to compare, in the same subjects, the cholesterol-lowering potential of a dietary portfolio with that of a statin.
Design: Thirty-four hyperlipidemic participants underwent all three 1-mo treatments in random order as outpatients: a very-low-saturated-fat diet (control diet), the same diet plus 20 mg lovastatin (statin diet), and a diet high in plant sterols (1.0 g/1000 kcal), soy-protein foods (including soy milks and soy burgers, 21.4 g/1000 kcal), almonds (14 g/1000 kcal), and viscous fibers from oats, barley, psyllium, and the vegetables okra and eggplant (10 g/1000 kcal) (portfolio diets). Fasting blood samples were obtained at 0, 2, and 4 wk.
Results: LDL-cholesterol concentrations decreased by 8.5 ± 1.9%, 33.3 ± 1.9%, and 29.6 ± 1.3% after 4 wk of the control, statin, and portfolio diets, respectively. Although the absolute difference between the statin and the portfolio treatments was significant at 4 wk (P = 0.013), 9 participants (26%) achieved their lowest LDL-cholesterol concentrations with the portfolio diet. Moreover, the statin (n = 27) and the portfolio (n = 24) diets did not differ significantly (P = 0.288) in their ability to reduce LDL cholesterol below the 3.4-mmol/L primary prevention cutoff.
Conclusions: Dietary combinations may not differ in potency from first-generation statins in achieving current lipid goals for primary prevention. They may, therefore, bridge the treatment gap between current therapeutic diets and newer statins.
Key Words: National Cholesterol Education Program diet blood lipids almonds soy protein viscous dietary fiber plant sterols low saturated fat treatment goals
Related articles in AJCN:
This article has been cited by other articles:
![]() |
S. Shrestha, J. S. Volek, J. Udani, R. J.Wood, C. M. Greene, D. Aggarwal, J. H. Contois, B. Kavoussi, and M. L. Fernandez A Combination Therapy Including Psyllium and Plant Sterols Lowers LDL Cholesterol by Modifying Lipoprotein Metabolism in Hypercholesterolemic Individuals J. Nutr., October 1, 2006; 136(10): 2492 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N Woods Nutrition Academic Award: nutrition education in graduate medical education. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 971S - 975S. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Jenkins, C. W. Kendall, D. A Faulkner, T. Nguyen, T. Kemp, A. Marchie, J. M. Wong, R. de Souza, A. Emam, E. Vidgen, et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia Am. J. Clinical Nutrition, March 1, 2006; 83(3): 582 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dewell, P. L. W. Hollenbeck, and C. B. Hollenbeck A Critical Evaluation of the Role of Soy Protein and Isoflavone Supplementation in the Control of Plasma Cholesterol Concentrations J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 772 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Moruisi, W. Oosthuizen, and A. M. Opperman Phytosterols/Stanols lower cholesterol concentrations in familial hypercholesterolemic subjects: a systematic review with meta-analysis. J. Am. Coll. Nutr., February 1, 2006; 25(1): 41 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J.A. Jenkins, C. W.C. Kendall, and A. Marchie Diet and Cholesterol Reduction Ann Intern Med, May 3, 2005; 142(9): 793 - 795. [Full Text] [PDF] |
||||
![]() |
M. A Denke Reviewing your investment strategy: where does diet fit in your personal portfolio Am. J. Clinical Nutrition, February 1, 2005; 81(2): 339 - 340. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |